North America Cancer Immunotherapy Market by Application - (Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others), by Product Type – (Monoclonal Antibodies, Checkpoint inhibitors/immune modulators, Therapeutic cancer vaccines, Oncolytic virus immunotherapy, Cytokines, Adoptive T cell transfer, Adjuvant Immunotherapy, Interferons, Interleukins, BCG and others) by Mode of Administration – (Intravenous, Oral, Topical, Intravesical), by End users (Hospitals, Clinics) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
- Advertising -
The North America Cancer Immunotherapy Market was worth $ 28.52 Billion in 2016 and estimated to reach $ 50.71 Billion by the end of 2021 with a growing potential of 12.20 %.
View report: marketdataforecast.com/market-repo…apy-market-1413/
North America is projected to dominate the market due to increased rates of death and morbidity of cancer sufferer and escalating awareness about cancer by the government increases patient’s treatment.
Immunotherapy is a type a treatment option used to treat the cancer by boosting the body’s natural defences to fight against the cancer cells. It helps to improve the immune system function by using the components made in the body or from the laboratory.
- Advertising -
Cancer immunotherapy helps in inhibiting the growth of the cancer cells, stopping the cancer cells from spreading across the body, helping the immune system to fight better against the cancer cells. However, high effectiveness of treatment by cancer immunotherapy and less side effects associated with the treatments witness lucrative growth during the forecast period.
North America cancer immunotherapy Market is primarily driven by increasing occurrence of cancer, Changing life style, Smoking and excessive alcoholic intake, high efficacy of immunotherapy compared to other treatments, less side effects associated with cancer immunotherapy, reduced chance of recurrence of cancer. Various cancers like Melanoma shows resistance towards chemotherapy and radiation therapies, Cost of cancer therapies, limited information on cancer immunobiology are the major factor hindering the growth of the market.
North America Cancer immunotherapy market is segmented based on Application into Breast, Lung, Melanoma, Colorectal, Head & Neck, Prostate and others. Based on product type, the market is segmented into Monoclonal Antibodies, Checkpoint inhibitors/immune modulators, Therapeutic cancer vaccines, Oncolytic virus immunotherapy, Cytokines, Adoptive T cell transfer, Adjuvant Immunotherapy, BCG and others.
Based on Mode of administration, the market is segmented into Intravenous, Oral, Topical, and Intravesical. Based on end users, the market is categorized into hospitals, clinics.
Based on Geography, the North America Cancer immunotherapy market is analysed under various regions namely U.S, and Canada.
Some of the major companies influencing in North America cancer immunotherapy Market are F. Hoffmann-La Roche Ltd, Amgen, Viralytics, Novartis Pharmaceuticals Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals Limited, AstraZeneca plc, Medivation, Advaxis, Bristol-Myers Squibb, Merck & Co.
and Celgene Corp, Immunomedics.
Cancer Immunotherapy Market Segmentation:
- Head & Neck
- Monoclonal Antibodies
- Checkpoint inhibitors/immune modulators
- Therapeutic cancer vaccines
- Oncolytic virus immunotherapy
Mode of Administration
- Intra Vesical
- Y-o-Y Growth Analysis, By End users
- Market Attractiveness Analysis, By End users
- Market Share Analysis, By End users
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: